Detalhe da pesquisa
1.
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Cell
; 182(1): 200-225.e35, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649874
2.
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.
Nature
; 601(7893): 434-439, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937944
3.
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer.
Proc Natl Acad Sci U S A
; 121(15): e2322563121, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557192
4.
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.
Proc Natl Acad Sci U S A
; 120(49): e2314416120, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011559
5.
Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.
Nature
; 629(8011): E9, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649489
6.
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.
Proc Natl Acad Sci U S A
; 118(24)2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099557
7.
AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.
Proc Natl Acad Sci U S A
; 118(20)2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972443
8.
Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2.
Proc Natl Acad Sci U S A
; 118(1): e2021450118, 2021 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33310900
9.
Highly Recurrent IDH1 Mutations in Prostate Cancer With Psammomatous Calcification.
Mod Pathol
; 36(6): 100146, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828361
10.
Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinoma.
Histopathology
; 82(5): 684-690, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564980
11.
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.
BMC Cancer
; 22(1): 494, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513774
12.
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.
Mod Pathol
; 34(8): 1596-1607, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33854184
13.
Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature.
Histopathology
; 76(6): 875-887, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872452
14.
Osthole ameliorates neurogenic and inflammatory hyperalgesia by modulation of iNOS, COX-2, and inflammatory cytokines in mice.
Inflammopharmacology
; 27(5): 949-960, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29736690
15.
Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
Med Oncol
; 41(3): 76, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38393424
16.
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.
Am J Surg Pathol
; 48(2): 163-173, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994665
17.
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer.
bioRxiv
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586029
18.
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.
bioRxiv
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464251
19.
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer.
bioRxiv
; 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464081
20.
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer.
bioRxiv
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562800